J&J | JNJ - Gewinn Vor Steuern

Aktienkurs
226.97
Täglich Wechseln
-0.82 -0.36%
Monatlich
-6.40%
Jährlich
45.21%
Q2 Prognose
222.63




Gewinn Vor Steuern Veränderung Datum
AbbVie USD 2.67B 1.71B 2025-12
Abbott USD 2.39B 27M 2026-03
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 2.63B 615M 2025-12
Baxter International USD 121M 12M 2025-09
Bayer EUR -1.16B 735M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Biogen USD -56M 613.3M 2025-12
Boston Scientific USD 700M 238M 2025-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merck USD 6.74B 22M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Novartis USD 4.64B 445M 2025-12
Pfizer USD 3.33B 290M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 887M 15M 2025-09